Format

Send to

Choose Destination
Eur J Gastroenterol Hepatol. 2011 Sep;23(9):801-6. doi: 10.1097/MEG.0b013e3283489dcf.

Barrett's, blood groups and progression to oesophageal cancer: is nitric oxide the link?

Author information

1
UK National Barrett's Oesophagus Registry, University College London, Department of Surgery and Interventional Science, Royal Free Hospital, Rotherham, UK. c.caygill@ucl.ac.uk

Abstract

INTRODUCTION:

Incidence of oesophageal adenocarcinoma (OAC) is increasing rapidly. OAC arises in columnar-lined oesophagus (CLO), a metaplastic change affecting some patients with gastro-oesophageal reflux disease (GORD). As yet there is no reliable method of identifying those at highest risk. Our earlier observation of an association between OAC and blood group O Rhesus negative, if confirmed, may help identify those at greatest risk.

AIM AND METHODS:

To assess the distribution of blood group and Rhesus D (RhD) factor in patients with GORD compared with the blood donating general population. GORD was categorized as nonerosive reflux (NER), erosive oesophagitis, CLO and OAC. The Rotherham Hospital database holds details of all GORD, CLO and OAC patients seen in the Gastroenterology Unit. Blood group information for patients with GORD was obtained from patients' records and the hospital's blood transfusion service. The blood group distribution in the general population was obtained from the National Blood Transfusion Service. The number of expected to observed patients in each blood group for each subtype was compared.

RESULTS:

Two thousand six hundred and ten NER, 2813 erosive oesophagitis, 568 CLO and 73 OAC patients had a recorded blood group. For RhD positive patients observed proportions in each blood group were similar to expected. The most striking difference was the marked excess of OAC in blood group O, Rhesus negative (P=0.002).

CONCLUSION:

CLO patients with blood group O, RhD negative carry a disproportionately higher risk of developing OAC. The mechanism is unknown but the finding has practical application in guiding risk stratification and intensity of surveillance.

PMID:
21701391
DOI:
10.1097/MEG.0b013e3283489dcf
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center